Acceleron Pharma Inc.

États‑Unis d’Amérique

 
Quantité totale PI 359
Rang # Quantité totale PI 3 585
Note d'activité PI 3,1/5.0    185
Rang # Activité PI 3 717
Symbole boursier XLRN (nasdaq)
ISIN US00434H1086
Capitalisation 6,900M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

207 0
52 0
100 0
0
 
Dernier brevet 2025 - Tgf-beta receptor type ii fusion...
Premier brevet 2005 - Alk7 and myostatin inhibitors an...

Derniers inventions, produits et services

2024 Invention Tgf-beta receptor type ii fusion proteins and uses thereof. In certain aspects, the present disc...
Invention Actrii proteins for the treatment of pulmonary arterial hypertension (pah). In some aspects, the...
Invention Actrii proteins and use in treating post-capillary pulmonary hypertension. In some aspects, the ...
Invention Actriib binding agents and uses thereof. The disclosure provides, among other aspects, neutraliz...
Invention Multispecific binders of tgfbeta-superfamily ligands and uses thereof. In certain aspects, the d...
Invention Alk4:actriib heteromultimers and uses thereof. In certain aspects, the disclosure provides solub...
Invention Activin type 2 receptor binding proteins and methods of making them. This disclosure provides Ac...
Invention Alk7 antagonists and uses thereof. In certain aspects, the disclosure provides ALK7 antagonists....
Invention Methods for treating myeloproliferative disorders. In part, the present disclosure relates metho...
Invention Alk7 binding proteins and uses thereof. This disclosure provides ALK7-binding proteins such as a...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the invention tea...
Invention Method for promoting bone growth using activin-actriia antagonists. In certain aspects, the pres...
2023 Invention Compositions and methods for treating spinal muscular atrophy. In certain aspects, the disclosur...
Invention Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereof. In certain as...
Invention Treatments for complications associated with chronic liver disease. In certain aspects, the pres...
Invention Treatments for hermansky-pudlak syndrome. In certain aspects, the present disclosure relates to ...
Invention Twisted gastrulation polypeptides and uses thereof. In certain aspects, the present invention pro...
2022 Invention Activin-actrii antagonists and uses for treating anemia. Provided herein are methods for the tre...
Invention Compositions and methods for treating renal diseases or conditions. In some aspects, the disclos...
Invention Compositions and methods for treating renal diseases or conditions. In some aspects, the disclosu...
Invention Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and me...
Invention Actrii proteins and uses thereof. In some aspects, the disclosure relates to compositions and met...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure re...
Invention Compositions and methods for treating pulmonary hypertension. In some aspects, the disclosure rel...
Invention Actrii proteins and uses thereof. e.g.e.g.e.g., pulmonary hypertension associated with chronic ob...
Invention Actrii-alk4 antagonists and methods of treating heart failure. In some aspects, the disclosure r...
2021 Invention Formulations comprising actrii polypeptide variants. In certain aspects, the present disclosure ...
Invention Single-arm actriia and actriib heteromultimers and methods for treating renal diseases or conditi...
Invention Variant actriib proteins and uses thereof. In certain aspects, the present invention provides no...
2020 Invention Single-arm actriia and actriib heteromultimers and methods for treating pulmonary hypertension. ...
Invention Treatments for systemic sclerosis. In certain aspects, the present disclosure relates to methods...
2019 Invention Multispecific binders of tgfbeta-superfamily ligands and uses thereof. In certain aspects, the di...